Julienne Brackett

1.7k total citations
28 papers, 1.3k citations indexed

About

Julienne Brackett is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Julienne Brackett has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pediatrics, Perinatology and Child Health, 11 papers in Public Health, Environmental and Occupational Health and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Julienne Brackett's work include Childhood Cancer Survivors' Quality of Life (14 papers), Acute Lymphoblastic Leukemia research (8 papers) and Diabetes Management and Research (6 papers). Julienne Brackett is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (14 papers), Acute Lymphoblastic Leukemia research (8 papers) and Diabetes Management and Research (6 papers). Julienne Brackett collaborates with scholars based in United States and Canada. Julienne Brackett's co-authors include Lori M. Laffel, Barbara J. Anderson, Dianne M. Finkelstein, Joyce Ho, Brian J. Anderson, Bat-Sheva Levine, Jeanne E. Antisdel, Deborah Butler, Joyce C. Ho and Eric S. Schafer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Diabetes Care.

In The Last Decade

Julienne Brackett

26 papers receiving 1.2k citations

Peers

Julienne Brackett
Fran R. Cogen United States
Jennifer Rohan United States
Jennifer K. Raymond United States
Katharine C. Garvey United States
Faisal Malik United States
Carol J. Howe United States
Sandra Cortina United States
Ian Blumer Canada
Jane K. Dickinson United States
Marja‐Terttu Saha Finland
Fran R. Cogen United States
Julienne Brackett
Citations per year, relative to Julienne Brackett Julienne Brackett (= 1×) peers Fran R. Cogen

Countries citing papers authored by Julienne Brackett

Since Specialization
Citations

This map shows the geographic impact of Julienne Brackett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julienne Brackett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julienne Brackett more than expected).

Fields of papers citing papers by Julienne Brackett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julienne Brackett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julienne Brackett. The network helps show where Julienne Brackett may publish in the future.

Co-authorship network of co-authors of Julienne Brackett

This figure shows the co-authorship network connecting the top 25 collaborators of Julienne Brackett. A scholar is included among the top collaborators of Julienne Brackett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julienne Brackett. Julienne Brackett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parsons, Susan K., Kathleen Montgomery, Julienne Brackett, et al.. (2025). Defining and measuring tolerability in pediatric, adolescent, and young adult oncology: The essential voices. Cancer. 131(S2). e35947–e35947.
2.
Stevens, Alexandra M., et al.. (2024). Levofloxacin prophylaxis for pediatric leukemia patients: monitoring of outcomes for sustained benefit and consequences. SHILAP Revista de lepidopterología. 4(1). e90–e90. 1 indexed citations
3.
4.
Frederick, Natasha N., James L. Klosky, Lillian R. Meacham, et al.. (2023). Fertility Preservation Practices at Pediatric Oncology Institutions in the United States: A Report From the Children's Oncology Group. JCO Oncology Practice. 19(4). e550–e558. 18 indexed citations
5.
Esbenshade, Adam J., Lillian Sung, Julienne Brackett, et al.. (2023). Children's Oncology Group's 2023 blueprint for research: Cancer control and supportive care. Pediatric Blood & Cancer. 70(S6). e30568–e30568. 2 indexed citations
6.
Stevens, Alexandra M., et al.. (2022). Levofloxacin prophylaxis for pediatric leukemia patients: Longitudinal follow‐up for impact on health care‐associated infections. Pediatric Blood & Cancer. 69(7). e29525–e29525. 12 indexed citations
7.
Prudowsky, Zachary D., et al.. (2022). Sinusoidal Obstruction Syndrome of the Liver Associated With 6-Mercaptopurine During Maintenance in a Child With T-cell Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 45(1). e121–e123. 1 indexed citations
8.
Mack, Jennifer W., et al.. (2022). Change in the Parent-Clinician Relationship Throughout the First Year of Treatment in Pediatric Oncology. JAMA Network Open. 5(9). e2230503–e2230503. 1 indexed citations
9.
Brackett, Julienne, Priya Mahajan, Kala Y. Kamdar, et al.. (2021). An evidence‐based, risk‐adapted algorithm for antifungal prophylaxis reduces risk for invasive mold infections in children with hematologic malignancies. Pediatric Blood & Cancer. 68(12). e29228–e29228. 3 indexed citations
10.
Schafer, Eric S., et al.. (2019). Use of allopurinol to reduce hepatotoxicity from 6-mercaptopurine (6-MP) in patients with acute lymphoblastic leukemia (ALL). Leukemia & lymphoma. 61(5). 1246–1249. 8 indexed citations
11.
Taylor, Olga A., Austin L. Brown, Julienne Brackett, et al.. (2018). Disparities in Neurotoxicity Risk and Outcomes among Pediatric Acute Lymphoblastic Leukemia Patients. Clinical Cancer Research. 24(20). 5012–5017. 26 indexed citations
12.
Brackett, Julienne, et al.. (2018). Prevention of mercaptopurine‐induced hypoglycemia using allopurinol to reduce methylated thiopurine metabolites. Pediatric Blood & Cancer. 66(4). e27577–e27577. 11 indexed citations
13.
Brackett, Julienne, et al.. (2017). Treatment-related sinusoidal obstruction syndrome in children with de novo acute lymphoblastic leukemia during intensification. Cancer Chemotherapy and Pharmacology. 80(6). 1261–1264. 10 indexed citations
14.
Lindsay, Holly, et al.. (2016). Cefepime-Induced Neurotoxicity Despite Dose Adjustment for Renal Disease: A Brief Report and Review of the Literature. Journal of the Pediatric Infectious Diseases Society. 6(2). piw022–piw022. 17 indexed citations
15.
Schwartz, David D., Ernest Frugé, Larry Laufman, et al.. (2016). Predictors of Suboptimal Follow-up in Pediatric Cancer Survivors. Journal of Pediatric Hematology/Oncology. 39(3). e143–e149. 13 indexed citations
16.
Brackett, Julienne, Eric S. Schafer, Daniel H. Leung, & M. Brooke Bernhardt. (2013). Use of allopurinol in children with acute lymphoblastic leukemia to reduce skewed thiopurine metabolism. Pediatric Blood & Cancer. 61(6). 1114–1117. 26 indexed citations
17.
Brackett, Julienne, Kevin R. Krull, Michael E. Scheurer, et al.. (2012). Antioxidant enzyme polymorphisms and neuropsychological outcomes in medulloblastoma survivors: a report from the Childhood Cancer Survivor Study. Neuro-Oncology. 14(8). 1018–1025. 27 indexed citations
18.
Levine, Bat-Sheva, Barbara J. Anderson, Deborah Butler, et al.. (2001). Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes. The Journal of Pediatrics. 139(2). 197–203. 211 indexed citations
19.
Laffel, Lori M., Julienne Brackett, Joyce C. Ho, & Barbara J. Anderson. (1998). Changing the Process of Diabetes Care Improves Metabolic Outcomes and Reduces Hospitalizations. Quality Management in Health Care. 6(4). 53–53. 57 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fran R. Cogen Breakdown of academic impact, for papers by Jennifer Rohan Breakdown of academic impact, for papers by Jennifer K. Raymond Breakdown of academic impact, for papers by Katharine C. Garvey Breakdown of academic impact, for papers by Faisal Malik Breakdown of academic impact, for papers by Carol J. Howe Breakdown of academic impact, for papers by Sandra Cortina Breakdown of academic impact, for papers by Ian Blumer Breakdown of academic impact, for papers by Jane K. Dickinson Breakdown of academic impact, for papers by Marja‐Terttu Saha
Rankless by CCL
2026